Skip to content

Paracervical Block for Pain Associated With Laminaria Insertion

Paracervical Block for Pain Associated With Laminaria Insertion

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02454296
Enrollment
41
Registered
2015-05-27
Start date
2015-05-31
Completion date
2015-12-31
Last updated
2017-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain

Keywords

Laminaria

Brief summary

To assess if paracervical block is effective at reducing discomfort during placement of intracervical laminaria for pre-operative cervical preparation.

Detailed description

Pre-operative dilation of the cervix with use of osmotic dilators (e.g. laminaria, dilapan-S) is commonly done prior to pregnancy termination to make the procedure safer. This study seeks to assess whether paracervical blocks are effective at reducing pain associated with placement of laminaria. Secondarily, this study will evaluate if paracervical blocks are effective at reducing overall procedural pain and increasing overall patient satisfaction for the intracervical laminaria placement procedure.

Interventions

DRUGParacervical Block with lidocaine

Performance of paracervical block, using 18 mL of 1% lidocaine buffered with 2 mL 8.4% sodium bicarbonate, prior to laminaria insertion

A capped needle will be placed on the cervix prior to laminaria insertion for purposes of blinding both the participant and research staff assessing outcomes

Sponsors

University of Hawaii
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 49 Years
Healthy volunteers
Yes

Inclusion criteria

* Pregnant women between the ages of 18-49 years * Desiring surgical termination of pregnancy or surgical management of a fetal demise * Treatment plan involves cervical preparation with laminaria * Participant able to provide informed consent in English and willing to participate in the study

Exclusion criteria

* Unable to read/speak/understand English * Contraindications to receiving lidocaine

Design outcomes

Primary

MeasureTime frameDescription
Pain After Placement of Laminaria (100 mm Visual Analog Scale)Measured within 10 seconds after placement of laminariaWe asked the participant to rate her pain on a 100 mm Visual Analog Scale (VAS) immediately after laminaria was placed. The VAS is a validated measure of pain where 0=no pain and 100=worst pain ever felt.

Secondary

MeasureTime frameDescription
Satisfaction With Overall Pain Control (100 mm Visual Analog Scale)15 minutes post-operativelyPatients rated their satisfaction with overall pain control on the 100 mm VAS, with 0 as not satisfied at all and 100 as completely satisfied
Paracervical or Sham Block PainWithin 10 seconds after receiving paracervical or sham blockParticipants reported her pain level on the 100 mm Visual Analog Scale (VAS) within 10 seconds after she received either the paracervical block or the sham block. The VAS is a validated measure of pain where 0=no pain and 100=worst pain ever felt.

Countries

United States

Participant flow

Recruitment details

Participants recruited from May 2015 to Dec 2015 at two of the faculty practice offices of the University of Hawaii Department of OB/gyn.

Participants by arm

ArmCount
Paracervical Block Group
Participants in this arm received a paracervical block consisting of 18 ml 1% lidocaine and 2 ml 8.4% sodium bicarbonate prior to the placement of laminaria.
20
Sham Block Group
Participants in this arm had a 20 ml syringe with a capped needle applied to the cervix.
21
Total41

Baseline characteristics

CharacteristicParacervical Block GroupSham Block GroupTotal
Age, Continuous25.80 years
STANDARD_DEVIATION 6.12
29.81 years
STANDARD_DEVIATION 6.92
27.85 years
STANDARD_DEVIATION 6.77
Race/Ethnicity, Customized
Asian
5 Participants9 Participants14 Participants
Race/Ethnicity, Customized
Black/African American
1 Participants0 Participants1 Participants
Race/Ethnicity, Customized
Hispanic/Latina
1 Participants1 Participants2 Participants
Race/Ethnicity, Customized
Native Hawaiian/Pacific Islander
10 Participants10 Participants20 Participants
Race/Ethnicity, Customized
White/Caucasian
5 Participants7 Participants12 Participants
Region of Enrollment
United States
20 Participants21 Participants41 Participants
Sex/Gender, Customized
Females
20 Participants21 Participants41 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 200 / 21
serious
Total, serious adverse events
0 / 200 / 21

Outcome results

Primary

Pain After Placement of Laminaria (100 mm Visual Analog Scale)

We asked the participant to rate her pain on a 100 mm Visual Analog Scale (VAS) immediately after laminaria was placed. The VAS is a validated measure of pain where 0=no pain and 100=worst pain ever felt.

Time frame: Measured within 10 seconds after placement of laminaria

ArmMeasureValue (MEDIAN)
Paracervical Block With LidocainePain After Placement of Laminaria (100 mm Visual Analog Scale)13 units on a scale (100 mm VAS)
Sham Paracervical BlockPain After Placement of Laminaria (100 mm Visual Analog Scale)54 units on a scale (100 mm VAS)
p-value: 0.01Wilcoxon (Mann-Whitney)
Secondary

Paracervical or Sham Block Pain

Participants reported her pain level on the 100 mm Visual Analog Scale (VAS) within 10 seconds after she received either the paracervical block or the sham block. The VAS is a validated measure of pain where 0=no pain and 100=worst pain ever felt.

Time frame: Within 10 seconds after receiving paracervical or sham block

ArmMeasureValue (MEDIAN)
Paracervical Block With LidocaineParacervical or Sham Block Pain14 units on a scale (100 mm VAS)
Sham Paracervical BlockParacervical or Sham Block Pain27 units on a scale (100 mm VAS)
p-value: 0.34Wilcoxon (Mann-Whitney)
Secondary

Satisfaction With Overall Pain Control (100 mm Visual Analog Scale)

Patients rated their satisfaction with overall pain control on the 100 mm VAS, with 0 as not satisfied at all and 100 as completely satisfied

Time frame: 15 minutes post-operatively

ArmMeasureValue (MEDIAN)
Paracervical Block With LidocaineSatisfaction With Overall Pain Control (100 mm Visual Analog Scale)95 units on a scale (100 mm VAS)
Sham Paracervical BlockSatisfaction With Overall Pain Control (100 mm Visual Analog Scale)70 units on a scale (100 mm VAS)
p-value: 0.05Wilcoxon (Mann-Whitney)

Source: ClinicalTrials.gov · Data processed: Feb 26, 2026